Correlation of intra-tumor18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Tixier, Florent ^a   Groves, Ashley M ^b   Goh, Vicky ^c   Hatt, Mathieu ^a   Ingrand, Pierre ^d   Cheze Le Rest, Catherine ^d   Visvikis, Dimitris ^a  

^a CHU MORVAN   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COLON BLOOD FLOW; COLORECTAL CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; MALE; PET SCANNER; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; TISSUE PERFUSION; TUMOR VASCULARIZATION; COLORECTAL NEOPLASMS; DIAGNOSTIC USE; GENETIC HETEROGENEITY; IMAGE QUALITY; PATHOLOGY; PROCEDURES; TUMOR VOLUME;

COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GENETIC HETEROGENEITY; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84903171026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099567     Document Type: Article

References (42)

1. Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB 3rd, et al. (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control final report of intergroup 0114. J Clin Oncol 20: 1744-1750. (Pubitemid 34273262)
2. Hebertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM (2009) Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clinical radiology 64: 225-237.
3. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, et al. (2009) Perineural invasion is independent predictor of outcome in colorectal cancer. J Clin Oncol 27: 5131-5137.
4. Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM (2010) [18F]FD PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J 86: 174-182.
5. Vikram R, Iyer RB (2008) PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8: S46-S51.
6. Dimitrakopoulou-Strauss A, Strauss LG, Rudi J (2003) PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Q J Nucl Med 47: 8-13. (Pubitemid 36826756)
7. Hendlisz A, Golfinopuloulos V, Garcia C, Covas A, Emonts P, et al. (2011) Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Ann Oncol 23: 1687-1693.
8. de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graff WT, Oyen WJ (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 50S1: 43S-54S.
9. Tixier F, Cheze Le Rest C, Hatt M, Albarghach N, Pradier O, et al. (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predict response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52: 369-378.
10. Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, et al. (2013) Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54: 19-26.
11. El Naqa I, Grigsby PW, Apte A, Kidd E, Donnelly E, et al. (2009) Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 42: 1162-1171.
12. Basu S, Kwee TC, Gatenby R, Saboury B, Torigian DA, et al. (2011) Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastic sites, a plausible explanation for failed attempts to cure malignant disorders. Eur J Nucl Med Mol Imaging 38: 987-991.
13. Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, et al. (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62: 545-553. (Pubitemid 40704474)
14. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, et al. (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT - Do tumor perfusion measurements reflect angiogenesis? Radiology 249: 510-517.
15. Lazanyi KS, Abramyuk A, Wolf G, Tokalov S, Zöphel K, et al. (2010) Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy. Lung Cancer 70: 280-285.
16. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A (2007) CT Perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma. Radiology 244: 486-493. (Pubitemid 47080881)
17. Weidner N. (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19.
18. th ed. Philadephia: Lippincott-Raven.
19. Hatt M, Cheze le Rest C, Turzo A, Roux C, Visvikis D (2009) A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans Med Imaging 28: 881-893.
20. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, et al. (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2: 159-171.
21. Haralick RM, Shanmugam K, Dinstein I (1973) Textural features for image classification. IEEE Trans Syst Man Cybern 3: 610-621.
22. Thibault G, Fertil B, Navarro C, Pereira S, Cau P, et al. (2009) Texture indexes and gray level size zone matrix: application to cell nuclei. Pattern Recognition Inf Process 140-145.
23. 18F-FDG PET imaging. J Nucl Med 53: 693-700.
24. Willaime JMY, Turkheimer FE, Kenny LM, Aboagye EO (2013) Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography. Phys Med Biol 58: 187-203.
25. Hatt M, Tixier F, Cheze-Le-Rest C, Pradier O, Visvikis D (2013) Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40: 1662-1671.
26. Tsushima Y, Funabasama S, Sanada S, Aoki J, Endo K (2009) Development of perfusion CT software for personal computers. Acad Radiol 9: 922-926.
27. Kanda T, Yoshikawa T, Ohno Y, Kanata N, Takenaka D, et al. (2012) CT hepatic perfusion measurement: Comparison of three analytic methods. Eur J Radiol 81: 2075-2079.
28. van Velden FHP, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, et al. (2011) Evaluation of cumulative SUV-volume histogram method for parameterizing heterogenous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38: 1636-1647.
29. Rajendran JG, Schwartz DL, O'Sullivan J, Peterson LM, Ng P, et al. (2006) Tumor hypoxia imaging with 18F fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12: 5435-5441. (Pubitemid 44497258)
30. Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, et al. (2003) Overexpression of Glut-1 and increased with oral squamous cell carcinoma. Cancer 97: 1015-1024.
31. García-Figueiras R, Goh VJ, Padhani AR, Baleato-González S, et al. (2013) CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 200: 8-19.
32. Rajpopat M, Miles KA (2012) Imaging vascular-metabolic relationships in tumors. Diagnostic imaging Europe 1: 11-14.
33. Janssen MHM, Aerts HJWL, Buijsen J, Lambin P, Lammering G, et al. (2012) Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion. Int. J. Radiation Oncology Biol. Phys 82: 849-855.
34. Groves AM, Wishart GC, Shastry M, Moyle P, Iddles S, et al. (2011) Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging 36: 416-421.
35. Hirasawa S, Tsushima Y, Takei H, Hirasawa H, Taketomi-Takahashi A, et al. (2007) Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. Acad Radiol 14: 312-318. (Pubitemid 46329457)
36. Bisdas S, Spicer K, Rumboldt Z (2008) Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR AM J Neuroradiol 29: 1376-1381.
37. Miles KA, Griffiths MR, Keith CT (2006) Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 33: 22-28. (Pubitemid 41785305)
38. Goh V, Engledow A, Rodriguez-Justo M, Shastry M, Peck J, et al. (2012) The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/Perfusion CT with histologic correlation. J Nucl Med 53: 687-692.
39. Kan Z, Phongkitkarun S, Koyabashi S, Tang Y, Ellis LM, et al. (2005) Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology 237: 151-158. (Pubitemid 41346159)
40. Goh V, Bartram C, Halligan S (2009) Effect of intravenous contrast agent volume on colorectal cancer vascular parameters as measured by perfusion computed tomography. Clin Radiol 64: 368-372.
41. Goh V, Liaw J, Bartram CI, Halligan S (2008) Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques. AJR Am J Roentgenol 191: W288-292.
42. Win T, Miles KA, Janes SM, Ganeshan B, Shastry M, et al. (2013) Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clin Cancer Res 19: 3591-3599.